Linda Peckel

Dermatoses of the skin, and their relevance to the early detection of many systemic forms of cancer, are reviewed.

An overview of the history of genome-wide association studies (GWAS) for osteoporosis, and the existing challenges and recent developments in GWAS in the bone field.

Several studies have assessed the potentially increased rate and the management of osteoporotic and fragility fractures during the COVID-19 pandemic.

Obesity has many effects on the skin, and physicians should be aware of the conditions common to their patients in order to diagnosis and treat the dermatoses of obesity.

Burnout is thought to be the direct result of occupational demands that consistently outweigh the physical, mental, and psychological abilities of individuals suffering from it.

Estimates indicate that ~1.4 million people self-identify as transgender in the United States, which is double the initial estimate is made by the Williams Institute in 2011.

In an effort to effectively address global health concerns, the WHO has announced the 13th General Programme of Work, a 5-year strategic plan spanning from 2019 to 2023.

Skin disorders, particularly those with known inflammatory mechanisms, may be considered potential early markers for the development of insulin resistance leading to metabolic syndrome, type 2 diabetes, and cardiovascular disease.

Obesity has a substantial effect on general health parameters, but its role in rheumatoid arthritis is much more complex.

The 2017 revisions to the Common Rule deal largely with improving the transparency and clarity of intended uses under the current standard of informed consent while introducing a new concept of “broad consent” that can significantly expand the reach of research that continues to yield new and important information.

Increasing waist circumference in midlife increases the risk of cognitive decline in late life.

Hyperglycemia treatment was left to physician’s discretion.

Accountable Care Organizations have potential to improve the quality of and access to care, with continued evaluation and adaptation.

The prevalence of diabetes and impairment in glucose metabolism are noticeably higher in psychiatric patients.

Current overall costs for medical liability in the United States range from $55.6 to $200 billion annually, which accounts for 2.4% to 10% of all healthcare spending.

Despite improved coverage, many Medicaid beneficiaries experienced increased wait times.

A number of organizations recently raised ethical concerns linked to researchers not reporting negative results of clinical trials.

A large number of product recalls for various medical devices indicates the need for more regulation prior to approval, and more active monitoring after devices hit the market.

The FDA has released draft guidance documents for appropriate marketing communication on medical products and devices.

The study supports previous findings of hyperarousal of the inflammatory system as a mechanism of insulin resistance.